Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression

Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression

Abstract Background To evaluate the anatomic site(s) of initial disease progression in patients with castration resistant metastatic prostate cancer (mCRPC) in the presence or absence of pre-treatment visceral metastases while on systemic therapy. Methods This is a retrospective cohort study of mCRP...

Full description

Bibliographic Details
Main Authors: Kathleen Ruchalski, Hyun J. Kim, Michael Douek, Steven Raman, Maitraya Patel, Victor Sai, Antonio Gutierrez, Benjamin Levine, Cheryce Fischer, Martin Allen-Auerbach, Pawan Gupta, Heidi Coy, Bianca Villegas, Matthew Brown, Jonathan Goldin
Format: Article
Language:English
Published: BMC 2022-07-01
Series:Cancer Imaging
Subjects:
RECIST
Disease progression
Prostate cancer
Visceral metastases
Online Access:https://doi.org/10.1186/s40644-022-00469-z

Internet

https://doi.org/10.1186/s40644-022-00469-z

Similar Items